title: Miliary tuberculosis after infliximab therapy in Lebanon.
authors.forename: Imad
authors.initials: I
authors.lastname: Uthman
authors.forename: Nadim
authors.initials: N
authors.lastname: Kanj
authors.forename: Jinane
authors.initials: J
authors.lastname: El-Sayad
authors.forename: Abdul-Rahman
authors.initials: AR
authors.lastname: Bizri
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000995:Antitubercular Agents / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000009:adverse effects*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab; D007861:Lebanon; D008297:Male; D009169:Mycobacterium tuberculosis; D011241:Prednisone / Q000627:therapeutic use; D017511:Pyoderma Gangrenosum / Q000188:drug therapy; D014391:Tuberculosis, Miliary / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology
chemical_list: D000911:Antibodies, Monoclonal; D000995:Antitubercular Agents; D003879:Dermatologic Agents; D005938:Glucocorticoids; D000069285:Infliximab; D011241:Prednisone